Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.40 |
| ▸ | FDPS | P14324 | 3/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ADH1B | P00325 | 1/20 | 0.38 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | ADH7 | P40394 | 1/20 | 0.38 |
| ▸ | LAP3 | P28838 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11570264 | 1.00 | GPR84 (0.40) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL11122020 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL18636577 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL18636377 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL11117118 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL8327728 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL11121462 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL21199582 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL21283607 | 0.95 | GPR84 (0.43) | GPR84FDPSFFAR1LMNAMAPT | |
| SCHEMBL8052236 | 0.93 | DNM1 (0.46) | GPR84FDPSFFAR1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170258861-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | SQUIRES MERYL J (US) | 2017-09-14 | — | — | US | disclosed |
| US-9662360-B2 | Treatment of herpes, pseudomonas, staph, and hepatitis | MERITUS CORPORATION (DM) | 2017-05-30 | — | — | US | disclosed |
| US-20160151436-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | MERITUS CORPORATION (DM) | 2016-06-02 | — | — | US | disclosed |
| US-8188184-B2 | Additive and vehicle for inks, paints, coatings and adhesives | OMNITECH ENVIRONMENTAL, LLC (US) | 2012-05-29 | — | — | US | disclosed |
| US-20110086957-A1 | ADDITIVE AND VEHICLE FOR INKS, PAINTS, COATINGS AND ADHESIVES | COOK LEROY JOHN | 2011-04-14 | — | — | US | disclosed |
| US-7863485-B2 | Additive and vehicle for inks, paints, coatings and adhesives | OMNITECH ENVIRONMENTAL, LLC (US) | 2011-01-04 | — | — | US | disclosed |
| US-20090191288-A1 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | SQUIRES MERYL J | 2009-07-30 | — | — | US | disclosed |
| US-20070277906-A1 | Water-Based Metal Treatment Composition | MIDDLESEX SILVER CO., LIMITED (GB) | 2007-12-06 | — | — | US | disclosed |
| EP-0980203-B1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 2007-04-04 | — | — | EP | disclosed |
| US-20070039665-A1 | Enhancing silver tarnish-resistance | MIDDLESEX SILVER CO. LIMITED (GB) | 2007-02-22 | — | — | US | disclosed |
| US-3984408-A | Sulfosuccinate derivatives as detergent builders | LEVER BROTHERS COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
| US-3976642-A | Sulfosuccinate derivatives as detergent builders | LEVER BROTHERS COMPANY (US) | 1976-08-24 | — | — | US | disclosed |
| US-3976586-A | Monoesters derived from ethoxylated higher alcohols and thiodisuccinic acid as detergent builders | GAF CORPORATION (US) | 1976-08-24 | — | — | US | disclosed |
| US-3970653-A | Sulfosuccinate derivatives as detergent builders | LEVER BROTHERS COMPANY (US) | 1976-07-20 | — | — | US | disclosed |
| US-3968110-A | PHENYL | LEVER BROTHERS COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3957775-A | SULFOSUCCINATE DERIVATIVES AS DETERGENT BUILDERS | LEVER BROTHERS COMPANY (US) | 1976-05-18 | — | — | US | disclosed |
| US-3950331-A | SULFOSUCCINATE DERIVATIVES AS DETERGENT BUILDERS | LEVER BROTHERS COMPANY (US) | 1976-04-13 | — | — | US | disclosed |
| US-3950260-A | SURFACTANTS | ELDIB ENGINEERING AND RESEARCH INC., | 1976-04-13 | — | — | US | disclosed |
| US-3936448-A | DETERGENTS, BUILDERS | LEVER BROTHERS COMPANY (US) | 1976-02-03 | — | — | US | disclosed |
| US-3935206-A | Sulfosuccinate derivatives as detergent builders | LEVER BROTHERS COMPANY (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160151436-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | NISCH, CUTA, HRH1 | GPR84 1366/4885FDPS 2776/4885FFAR1 1761/4885 |
| US-20170258861-A1 | Treatment of Herpes, Pseudomonas, Staph, and Hepatitis | NISCH, CUTA, HRH1 | GPR84 1366/4885FDPS 2776/4885FFAR1 1761/4885 |
| US-20090191288-A1 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | ASPH, KCNH3, PRPH | GPR84 1421/4885FDPS 3214/4885FFAR1 1489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.